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TO THE EDITOR
In their longitudinal study of metabolically healthy workers, Chang and colleagues (1) 
showed that higher BMI categories were associated with an increased incidence of CKD. 
They interpreted this finding as an adverse consequence of adiposity. However, their 
description of participant subgroups suggests that the association reported between elevated 
BMI and incident CKD was driven by relationships found primarily among older adults, 
men, and persons who exercise frequently. These are subgroups in which BMI status might 
reflect variations in the preservation or formation of muscle mass rather than the 
accumulation of adipose tissue. Greater muscle mass leads to increased production of 
creatinine, which in turn is associated with a reduced estimated glomerular filtration rate 
(GFR) (2) consistent with the final row of Table 1 of the article. Reduction of the estimated 
GFR to less than 60 mL/min/1.73 m2 was the quantitative threshold for identifying incident 
events of CKD.
Our curiosity leads to testable hypotheses. We suggest that Chang and colleagues use their 
Kangbuk Samsung Health Study to assess whether the decline in the estimated GFR might 
be associated more strongly with baseline lean mass rather than adipose tissue. As the 
authors recently reported (3), their healthy-worker cohort also provided measurements of 
bioelectric impedance and waist circumference. Thus, baseline values can be calculated for 
the percentage of fat and fat-free mass and the waist–height ratio.
Controversies exist about how to interpret BMI (4, 5). To clarify how it contributes to the 
decline in the estimated GFR, the authors could consider which tissue components or 
anatomical distributions of body mass best predict the described outcome.
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